Publication:
The Intravaginal Application of Misoprostol Improves Induction of Abortion with Aglepristone

dc.authorscopusid25025882400
dc.authorscopusid6602956547
dc.authorscopusid16241671400
dc.authorscopusid25227564100
dc.authorscopusid36701338800
dc.authorscopusid28767674800
dc.authorscopusid25229878500
dc.contributor.authorAǧaoǧlu, A.R.
dc.contributor.authorSchäfer-Somi, S.
dc.contributor.authorKaya, D.
dc.contributor.authorKüçükaslan, I.
dc.contributor.authorEmre, B.
dc.contributor.authorGültiken, N.
dc.contributor.authorMülazimoǧlu, B.S.
dc.date.accessioned2020-06-21T14:39:56Z
dc.date.available2020-06-21T14:39:56Z
dc.date.issued2011
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Aǧaoǧlu] Ali Reha, Department of Obstetrics and Gynecology and Reproduction, Burdur Mehmet Akif Ersoy Üniversitesi, Burdur, Turkey; [Schäfer-Somi] Sabine, Centre for Artificial Insemination and Embryo Transfer, Veterinarmedizinische Universitat Wien, Vienna, Vienna, Austria; [Kaya] Duygu, Department of Obstetrics and Gynecology, Kafkas Üniversitesi, Veteriner Fakültesi, Kars, Turkey; [Küçükaslan] İbrahim, Department of Obstetrics and Gynecology, Ankara Üniversitesi, Ankara, Turkey; [Emre] Birten, Department of Obstetrics and Gynecology, Harran Üniversitesi, Sanliurfa, Turkey; [Gültiken] Nilgün, Department of Obstetrics and Gynecology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Mülazimoǧlu] Baris S., Department of Obstetrics and Gynecology, Ankara Üniversitesi, Ankara, Turkey; [Çolak] Armaǧan, Department of Obstetrics and Gynecology, Atatürk Üniversitesi, Erzurum, Erzurum, Turkey; [Aslan] Selim, Department of Obstetrics and Gynecology, Ankara Üniversitesi, Ankara, Turkeyen_US
dc.description.abstractThe aim of the present study was to compare the clinical and endocrinological effects of four different treatments for the induction of abortion in bitches. For this purpose, 28 pregnant bitches between days 25 and 35 of gestation, were randomly assigned to four groups. In group I (n = 7), only aglepristone (AGL, 10mg/kg bw, two injections 24 h apart, s.c.) was administered. In group II (n = 7), AGL (as in group I), cabergolin (CAB, 5 μg/kg, daily p.o., until completion of abortion) and misoprostol (MIS, 200 μg for bitches with ≤ 20 kg bw, 400 μg for bitches with > 20 kg bw, daily intravaginally, until completion of abortion) were administered. In group III (n = 7), AGL (as in group I) and MIS (as in group II) were administered. In group IV (n = 7) AGL, (as in group I) and cloprostenol (CLO, 1μg/kg bw, s.c., two injections 24 h apart with the AGL injections) were combined. In all groups, bitches were examined daily, clinically and ultrasonographically to monitor resorptions/abortions. To measure serum progesterone (P4) and total estrogen (TE) concentrations, blood samples were collected in all groups immediately after the first AGL administration and every other day until completion of abortion. No statistical differences were found between groups concerning the duration until completion of abortion following treatment (n.s.); however, in Group III, 6 d after the start of treatment all pregnancies were terminated whereas in Group I, II and IV, only 57.1% (4/7), 85.7 % (6/7) and 42.8 % (3/7) of pregnancies were terminated. In the latter groups, all pregnancies were terminated between days 8 and 10 after the start of treatment. In Group IV, P4 concentrations on days two and one before the beginning of abortion and the day the abortion started was significantly lower than in the other groups (P < 0.01). No statistical differences were found between groups for TE concentrations (P > 0.05). In Groups I, II and III, no severe side effects occurred. Severe vomiting after each treatment and until the end of abortion was observed in Group IV only. In conclusion, only when a combination of AGL and MIS was used abortion was completed within 6 d in all bitches whereas the additional use of CAB did not improve the treatment. © 2011 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.theriogenology.2011.01.019
dc.identifier.endpage82en_US
dc.identifier.issn1879-3231
dc.identifier.issue1en_US
dc.identifier.pmid21458052
dc.identifier.scopus2-s2.0-79957739305
dc.identifier.scopusqualityQ1
dc.identifier.startpage74en_US
dc.identifier.urihttps://doi.org/10.1016/j.theriogenology.2011.01.019
dc.identifier.volume76en_US
dc.identifier.wosWOS:000291843300008
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTheriogenologyen_US
dc.relation.journalTheriogenologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAbortionen_US
dc.subjectAglepristoneen_US
dc.subjectDogsen_US
dc.subjectMisoprostolen_US
dc.subjectPregnancy Terminationen_US
dc.titleThe Intravaginal Application of Misoprostol Improves Induction of Abortion with Aglepristoneen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files